Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathological Conditions, Anatomical » Constriction, Pathologic
Description
The condition of an anatomical structure's being constricted beyond normal dimensions. MeSH
Hierarchy View
Phase 4 Indicated Drugs (3)
Phase 2 Indicated Drugs (1)
Phase 1 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (63)
Australasian Gastro Intestinal Research Foundation (AGIRF)
Boryung Pharmaceutical Company
Canadian Medical and Surgical Knowledge Translation Research Group
China Academy of Chinese Medical Sciences
China International Medical Foundation
National Research Institute of Tuberculosis and Lung Disease, Iran
Oregon Health and Science University
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Organization Involved with Phase 3 Indications (24)
Organization Involved with Phase 2 Indications (34)
Assistance Publique - Hôpitaux de Paris
Belarusian Medical Academy of Post-Graduate Education
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (18)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.